Pharmacists in Caribou, Maine


13 Pharmacists found in Caribou
male pharmacist

Alan Norman Weissman


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735    

female pharmacist

Edwina Louise Morris


Pharmacist
114 High St, Caribou, ME 04736
207-498-3545     207-498-6062

female pharmacist

Emily Jean Weissman, PHARMD


Pharmacist - Pharmacotherapy
163 Van Buren Rd, Caribou, ME 04736
207-498-1225    



male pharmacist

Ian A. Macomber


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735    

male pharmacist

Joseph Annunzio Parisi, PHARMD, RPH


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735    

female pharmacist

Kaysie Nichole Dobson


Pharmacist
114 High St, Caribou, ME 04736
207-498-3545    

male pharmacist

Mr. Marco Beaulieu, RPH


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735    

male pharmacist

Michael Michaud


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
163 Van Buren Rd, Suite 6, Caribou, ME 04736
207-493-3839     207-493-3877

female pharmacist

Miranda Smith, PHARMD


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735    

male pharmacist

Nickolas Jacob Dobson, PHARMD


Pharmacist
163 Van Buren Rd, Caribou, ME 04736
207-498-1225    

female pharmacist

Dr. Olivia C Hudson, PHARMD


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-3785    

female pharmacist

Regina Ann Jones-morneault, RPH


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735     207-498-0902

female pharmacist

Sherri Demerchant, RPH


Pharmacist
112 Bennett Dr, Caribou, ME 04736
207-498-8735     207-498-0902


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.